Evidence map›Paper›PMID 21239441›Full record

ArticleEndocrinology2011

Differential and complementary effects of glucose and prolactin on islet DNA synthesis and gene expression.

Ramamani Arumugam, Donald Fleenor, Danhong Lu, Michael Freemark

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2023
    Article
  3. Article
  4. Modelling gestational diabetes mellitus: large animals hold great promise.Reviews in endocrine & metabolic disorders · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Defective prolactin signaling impairs pancreatic β-cell development during the perinatal period.American journal of physiology. Endocrinology and metabolism · 2013
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ramamani ArumugamDuke University Medical Center, Department of Pediatrics, Durham, North Carolina 27710, USA.
Donald Fleenor
Danhong Lu
Michael Freemark
Duke Medical Center · USDuke University · USDuke University Hospital · US

Funding

THE ROLE OF PLACENTAL LACTOGEN IN FETAL DEVELOPMENTR01HD024192 · NICHD · DUKE UNIVERSITY · PI FREEMARK, MICHAEL S. · 1988 to 2007
$2.2M
NICHD NIH HHS HD024192NICHD NIH HHS R01 HD024192
6 · The paper itself

Abstract

The mechanisms by which lactogenic hormones promote β-cell expansion remain poorly understood. Because prolactin (PRL) up-regulates β-cell glucose transporter 2, glucokinase, and pyruvate dehydrogenase activities, we reasoned that glucose availability might mediate or modulate the effects of PRL on β-cell mass. Here, we used male rat islets to show that PRL and glucose have differential but complementary effects on the expression of cell cyclins, cell cycle inhibitors, and various other genes known to regulate β-cell replication, including insulin receptor substrate 2, IGF-II, menin, forkhead box protein M1, tryptophan hydroxylase 1, and the PRL receptor. Differential effects on gene expression are associated with synergistic effects of glucose and PRL on islet DNA synthesis. The effects of PRL on gene expression are mirrored by β-cell overexpression of signal transducer and activator of transcription 5b and are opposed by dexamethasone. An ad-small interfering RNA specific for cyclin D2 attenuates markedly the effects of PRL on islet DNA synthesis. Our studies suggest a new paradigm for the control of β-cell mass and insulin production by hormones and nutrients. PRL up-regulates β-cell glucose uptake and utilization, whereas glucose increases islet PRL receptor expression and potentiates the effects of PRL on cell cycle gene expression and DNA synthesis. These findings suggest novel targets for prevention of neonatal glucose intolerance and gestational diabetes and may provide new insight into the pathogenesis of β-cell hyperplasia in obese subjects with insulin resistance.

Indexed as

AnimalsCells, CulturedCyclin D2Cyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent Kinase Inhibitor p57DNAForkhead Box Protein O1Forkhead Transcription FactorsGene Expression RegulationGlucoseIslets of LangerhansMaleNerve Tissue ProteinsProlactinRatsRats, WistarCcnd2 protein, ratCyclin D2Cyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent Kinase Inhibitor p57DNAForkhead Box Protein O1Forkhead Transcription FactorsFoxo1 protein, ratGlucoseMen1 protein, ratNerve Tissue ProteinsProlactinRNA, MessengerRNA, Small InterferingStat5b protein, ratSTAT5 Transcription FactorTranscription Factors

Identifiers

PMID21239441
PMCPMC3198965
OpenAlexW1965058435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.